{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:40:51Z","timestamp":1791589251019,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.atherosclerosis.2020.07.019","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T21:41:26Z","timestamp":1596058886000},"page":"116-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["The position of functional foods and supplements with a serum LDL-C lowering effect in the spectrum ranging from universal to care-related CVD risk management"],"prefix":"10.1016","volume":"311","author":[{"given":"Sabine","family":"Baumgartner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bruckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8887-994X","authenticated-orcid":false,"given":"Antonio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jogchum","family":"Plat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib1","article-title":"Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015","author":"Sundaram","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European society of cardiology: cardiovascular disease statistics 2017","volume":"39","author":"Timmis","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib3","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","author":"Boren","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Cholesterol Treatment Trialists","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib7","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2012.14312","article-title":"Lifetime risk and years lived free of total cardiovascular disease","volume":"308","author":"Wilkins","year":"2012","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib11","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980-2000","volume":"356","author":"Ford","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2020.07.019_bib13","first-page":"S1","article-title":"Scientific concepts of functional foods in Europe. Consensus document","volume":"81","year":"1999","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib14","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1126\/science.285.5435.1853","article-title":"Health - regulation of \"nutraceuticals\"","volume":"285","author":"Zeisel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev.nutr.22.020702.075220","article-title":"Phytosterols in human nutrition","volume":"22","author":"Ostlund","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.15420\/ecr.2010.6.3.18","article-title":"The effects of plant stanol ester in different subject groups","volume":"6","author":"Gylling","year":"2010","journal-title":"Eur. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2012.09.018","article-title":"Progress and prospective of plant sterol and plant stanol research: report of the Maastricht meeting","volume":"225","author":"Plat","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3945\/jn.108.095125","article-title":"Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake","volume":"139","author":"Demonty","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3389\/fphar.2019.01449","article-title":"Red yeast rice: a systematic review of the traditional uses, chemistry, pharmacology, and quality control of an important Chinese folk medicine","volume":"10","author":"Zhu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","article-title":"Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis","volume":"240","author":"Gerards","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib24","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1177\/2047487317715714","article-title":"Variability in strength of red yeast rice supplements purchased from mainstream retailers","volume":"24","author":"Cohen","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib25","first-page":"2304","article-title":"Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL cholesterol concentrations (ID 1648, 1700) pursuant to Article 13 (1) of Regulation (EC) No 1924\/2006","volume":"9","author":"EFSA","year":"2011","journal-title":"EFSA J"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib26","first-page":"5368","article-title":"Scientific opinion on the safety of monacolins in red yeast rice","volume":"16","author":"EFSA","year":"2018","journal-title":"EFSA J"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.atherosclerosissup.2019.08.023","article-title":"The role of red yeast rice (RYR) supplementation in plasma cholesterol control: a review and expert opinion","volume":"39","author":"Banach","year":"2019","journal-title":"Atherosclerosis Suppl."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.ejcn.1602607","article-title":"Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study","volume":"61","author":"Ellegard","year":"2007","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jn\/134.4.831","article-title":"A novel barley cultivar (Himalaya 292) with a specific gene mutation in starch synthase IIa raises large bowel starch and short-chain fatty acids in rats","volume":"134","author":"Bird","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1017\/S000711451600341X","article-title":"The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials","volume":"116","author":"Ho","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1370\/afm.917","article-title":"The effects of barley-derived soluble fiber on serum lipids","volume":"7","author":"Talati","year":"2009","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/ejcn.2008.49","article-title":"Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials","volume":"63","author":"Wei","year":"2009","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib33","article-title":"Food labeling: health claims; soluble fiber from certain foods and coronary heart disease","volume":"63","author":"FDA","year":"1998","journal-title":"Fed. Regist."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ejcn.2011.208","article-title":"Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women","volume":"66","author":"Brouns","year":"2012","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib35","author":"EFSA"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1541-4337.2007.00025.x","article-title":"Functional and edible uses of soy protein products","volume":"7","author":"Singh","year":"2008","journal-title":"Compr Rev Food Sci F"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amjcard.2006.03.042","article-title":"A meta-analysis of the effect of soy protein supplementation on serum lipids","volume":"98","author":"Reynolds","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib38","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/ajcn\/85.4.1148","article-title":"Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials","volume":"85","author":"Taku","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1017\/S0007114515002603","article-title":"Soya products and serum lipids: a meta-analysis of randomised controlled trials","volume":"114","author":"Tokede","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib40","doi-asserted-by":"crossref","first-page":"2302s","DOI":"10.3945\/jn.110.124958","article-title":"Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms","volume":"140","author":"Jenkins","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib41","author":"Health Canada"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib42","author":"EFSA"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbalip.2013.01.013","article-title":"Fat lowers fat: purified phospholipids as emerging therapies for dyslipidemia","volume":"1831","author":"Sahebkar","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00394-004-0492-0","article-title":"A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects","volume":"44","author":"Hoie","year":"2005","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib47","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1039\/C5FO01190F","article-title":"Cardiovascular benefits of probiotics: a review of experimental and clinical studies","volume":"7","author":"Thushara","year":"2016","journal-title":"Food Funct"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib49","article-title":"Effect of probiotics on blood lipid concentrations: a meta-analysis of randomized controlled trials","volume":"94","author":"Cho","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib50","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.numecd.2011.04.008","article-title":"Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials","volume":"21","author":"Guo","year":"2011","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/07853890.2015.1071872","article-title":"Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Sun","year":"2015","journal-title":"Ann. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.idairyj.2009.10.003","article-title":"Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract","volume":"20","author":"Lye","year":"2010","journal-title":"Int. Dairy J."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mnfr.201400548","article-title":"The perspective on cholesterol-lowering mechanisms of probiotics","volume":"59","author":"Ishimwe","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib54","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ptr.2399","article-title":"Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine","volume":"22","author":"Imanshahidi","year":"2008","journal-title":"Phytother Res."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib55","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib56","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2008.01.037","article-title":"Combination of simvastatin with berberine improves the lipid-lowering efficacy","volume":"57","author":"Kong","year":"2008","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib57","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1734-1140(12)70883-6","article-title":"Berberine inhibits dyslipidemia in C57BL\/6 mice with lipopolysaccharide induced inflammation","volume":"64","author":"Xiao","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0032-1328321","article-title":"The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials","volume":"79","author":"Dong","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jep.2014.09.049","article-title":"Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension","volume":"161","author":"Lan","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phymed.2018.09.212","article-title":"Efficacy and safety of berberine for dyslipidaemias: a systematic review and meta-analysis of randomized clinical trials","volume":"50","author":"Ju","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib61","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2015.09.032","article-title":"Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studies","volume":"243","author":"Pirillo","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib62","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/np900096w","article-title":"Statin-like principles of bergamot fruit (Citrus bergamia): isolation of 3-hydroxymethylglutaryl flavonoid glycosides","volume":"72","author":"Di Donna","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib63","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.clnu.2014.11.012","article-title":"The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease","volume":"34","author":"Impellizzeri","year":"2015","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib64","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1871530319666181203151513","article-title":"Hypoglycemic and hypolipemic effects of a new lecithin formulation of bergamot polyphenolic fraction: a double blind, randomized, placebo- controlled study","volume":"19","author":"Mollace","year":"2019","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib65","doi-asserted-by":"crossref","DOI":"10.15761\/IFNM.1000249","article-title":"Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers","volume":"6","author":"Nauman","year":"2019","journal-title":"Integr Food Nutr Metab"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/153537020422900301","article-title":"Nutritional significance and metabolism of very long chain fatty alcohols and acids from dietary waxes","volume":"229","author":"Hargrove","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00002512-200320020-00006","article-title":"Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia","volume":"20","author":"Castano","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2337\/diacare.18.3.393","article-title":"Treatment of hypercholesterolemia in niddm with policosanol","volume":"18","author":"Torres","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10408391003626249","article-title":"Policosanols as nutraceuticals: fact or fiction","volume":"50","author":"Marinangeli","year":"2010","journal-title":"Crit Rev Food Sci"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib70","doi-asserted-by":"crossref","DOI":"10.1007\/164_2019_341","article-title":"Prevention and treatment of atherosclerosis: the use of nutraceuticals and functional foods","author":"Visioli","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2891-13-101","article-title":"Consumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds","volume":"13","author":"Ramprasath","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib72","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9149(00)00976-0","article-title":"Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy","volume":"86","author":"Blair","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib73","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jada.2006.07.009","article-title":"Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins","volume":"106","author":"Cabezas","year":"2006","journal-title":"J. Am. Diet Assoc."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0021-9150(00)00653-5","article-title":"Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread","volume":"156","author":"Neil","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib75","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9149(02)02600-0","article-title":"Investigators. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia","volume":"90","author":"Simons","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib76","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCULATIONAHA.110.006692","article-title":"Combined effects of ezetimibe and phytosterols on cholesterol metabolism A randomized, controlled feeding study in humans","volume":"124","author":"Lin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib77","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1542\/peds.89.1.138","article-title":"Long-term treatment of severe familial hypercholesterolemia in children - effect of sitosterol and bezafibrate","volume":"89","author":"Becker","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib78","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1515\/CCLM.2001.103","article-title":"Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment","volume":"39","author":"Nigon","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib79","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1142\/S0192415X19500393","article-title":"Efficacy and safety of berberine alone or combined with statins for the treatment of hyperlipidemia: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"47","author":"Zhang","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib80","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2015.12.025","article-title":"Metabolic syndrome, adherence to the Mediterranean diet and 10-year cardiovascular disease incidence: the ATTICA study","volume":"246","author":"Kastorini","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12966-018-0677-1","article-title":"The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study","volume":"15","author":"Santo","year":"2018","journal-title":"Int. J. Behav. Nutr. Phys. Activ."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib82","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jhn.12508","volume":"31","author":"Sialvera","year":"2018","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib83","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1185\/03007995.2014.890924","article-title":"Dietary supplementation contributes to lifestyle improvement in hypercholesterolemic patients in real-life contexts","volume":"30","author":"Bruckert","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib84","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-277X.2011.01168.x","article-title":"The THEMA study: a sociodemographic survey of hypercholesterolaemic individuals","volume":"24","author":"Fournier","year":"2011","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib85","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S2213-8587(15)00480-5","article-title":"Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial","volume":"4","author":"Xavier","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1017\/S0029665112002844","article-title":"Personalised nutrition: ready for practice?","volume":"72","author":"de Roos","year":"2013","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib87","doi-asserted-by":"crossref","DOI":"10.3945\/an.113.005686","article-title":"Personalized nutrition and cardiovascular disease prevention: from Framingham to PREDIMED","volume":"5","author":"Konstantinidou","year":"2014","journal-title":"Adv Nutr"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib88","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5740\/jaoacint.SGEJones","article-title":"Inter-individual variability in response to plant sterol and stanol consumption","volume":"98","author":"Jones","year":"2015","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib89","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3945\/ajcn.114.095356","article-title":"Lathosterol-to-cholesterol ratio in serum predicts cholesterol-lowering response to plant sterol consumption in a dual-center, randomized, single-blind placebo-controlled trial","volume":"101","author":"Mackay","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3945\/ajcn.2009.29073","article-title":"High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy","volume":"92","author":"Rideout","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.appet.2017.02.031","article-title":"Consumers' acceptance and preferences for nutrition-modified and functional dairy products: a systematic review","volume":"113","author":"Bimbo","year":"2017","journal-title":"Appetite"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib92","doi-asserted-by":"crossref","first-page":"112574","DOI":"10.1016\/j.socscimed.2019.112574","article-title":"Longitudinal associations of neighborhood socioeconomic status with cardiovascular risk factors: a 46-year follow-up study","volume":"241","author":"Jimenez","year":"2019","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib93","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/eurpub\/ckq075","article-title":"Socio-economic status and prevention of cardiovascular disease in Italy: evidence from a national health survey","volume":"21","author":"Damiani","year":"2011","journal-title":"Eur. J. Publ. Health"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib94","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10198-017-0934-2","article-title":"The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study","volume":"19","author":"Yang","year":"2018","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib95","series-title":"Healthcare Cost Savings of Phytosterol Food Supplements in the European Union","author":"Frost","year":"2017"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib97","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012865","article-title":"Plant-based diets are associated with a lower risk of incident cardiovascular disease, cardiovascular disease mortality, and all-cause mortality in a general population of middle-aged adults","volume":"8","author":"Kim","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib98","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tcm.2018.02.004","article-title":"Plant-based diets and cardiovascular health","volume":"28","author":"Satija","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib99","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/nutrit\/nux030","article-title":"Association between plant-based diets and plasma lipids: a systematic review and meta-analysis","volume":"75","author":"Yokoyama","year":"2017","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pcad.2018.05.004","article-title":"Portfolio dietary pattern and cardiovascular disease: a systematic review and meta-analysis of controlled trials","volume":"61","author":"Chiavaroli","year":"2018","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib104","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.atherosclerosis.2013.11.043","article-title":"Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease","volume":"232","author":"Gylling","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.07.019_bib106","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1017\/S0007114514000750","article-title":"LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies","volume":"112","author":"Ras","year":"2014","journal-title":"Br. J. Nutr."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020303865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020303865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:43:56Z","timestamp":1758156236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915020303865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":97,"alternative-id":["S0021915020303865"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.07.019","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The position of functional foods and supplements with a serum LDL-C lowering effect in the spectrum ranging from universal to care-related CVD risk management","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}